Things are well and truly on track for clinical stage pharmaceutical company Pharmaxis (ASX: PXS), a sentiment confirmed by CEO Gary Phillips in his shareholder address in their recent quarterly results. The Company has made significant progress in three clinical trial programs, with plenty on the horizon for their preclinical pipeline too. Lead asset PXS-5505
Read More
Putting behind them the drama of 2021 which resulted in their former Chairman’s offices being raided by Australian Federal Police, medicinal cannabis company Creso Pharma (ASX: CPH) has kicked off the new year with a bang, confirming their entry into the lucrative US market through the acquisition of Sierra Sage Herbs. Founded in 2008 by
Read More
The social media giant Meta Platforms (NASDAQ: FB), formerly known as Facebook, issued disappointing guidance for the first quarter in addition to also falling short on its previous quarter user numbers and profit, leaving investors curious about the future of the company. Pivoting from the classic Facebook website and app, the Meta rebrand aims to
Read More
QR codes are having a major moment and I’m definitely not complaining. You’d be lying if you said you don’t enjoy the convenience of being able to order food and drinks to the table, from your phone. No interruptions to conversation, no waiters getting your order wrong, no weird judgemental faces when you reiterate for
Read More
If you’re trying to get a job by falsifying your education credentials, don’t even bother because it will most likely land you on some sort of blacklist with HR tech company Xref (ASX: XRF) adding a new education feature to their automated reference check platform. The new feature comes via an exclusive partnership with Higher
Read More
Cashing in on a business they have been incubating since 2016, microcap surveying company Veris (ASX: VRS) has reeled in a big fish via their sale of telecommunications subsidiary Aqura Technology to telco powerhouse Telstra (ASX: TLS) for $30 million. The $30m sale represents approximately 98% of Veris’ market capitalisation prior to the announcement. Since
Read More